financetom
Business
financetom
/
Business
/
Scotts Miracle-Gro Q3 sales miss
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scotts Miracle-Gro Q3 sales miss
Jul 30, 2025 4:49 AM

Overview

* Scotts Miracle-Gro ( SMG ) fiscal Q3 sales fall 1%, missing analyst expectations, per LSEG data

* Adjusted EPS for fiscal Q3 beats consensus, reflecting improved operational efficiency

* Company reaffirms full-year non-GAAP fiscal 2025 guidance, indicating confidence in strategy

Outlook

* Scotts Miracle-Gro ( SMG ) reaffirms full-year non-GAAP fiscal 2025 guidance

* Company expects U.S. Consumer net sales to grow low single-digit, excluding non-repeat sales

* Scotts Miracle-Gro ( SMG ) anticipates non-GAAP adjusted gross margin of ~30% for fiscal 2025

* Company projects non-GAAP adjusted EBITDA of $570 mln to $590 mln for fiscal 2025

* Scotts Miracle-Gro ( SMG ) expects non-GAAP adjusted EPS of at least $3.50 for fiscal 2025

* Company forecasts free cash flow of approximately $250 mln for fiscal 2025

Result Drivers

* PRODUCT MIX - Improved mix driven by non-recurrence of lower-margin sales and increased sales of higher-margin branded products

* LEVERAGE IMPROVEMENT - Leverage improved by over 1.3x compared to last year, reflecting better financial health

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Miss $1.19 $1.23

bln bln (8

Analysts

)

Q3 Beat $2.59 $2.27 (8

Adjusted Analysts

EPS )

Q3 EPS $2.54

Q3 Net $149.10

Income mln

Q3 Beat $256.10 $251 mln

Adjusted mln (7

EBITDA Analysts

)

Q3 Gross 378.0%

Margin

Q3 Basic $2.58

EPS

Q3 $215 mln

Operatin

g Income

Q3 $207.30

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the agricultural chemicals peer group is "hold."

* Wall Street's median 12-month price target for Scotts Miracle-Gro Co ( SMG ) is $75.00, about 9.5% above its July 29 closing price of $67.86

* The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sagtec Global Prices $7 Million IPO
Sagtec Global Prices $7 Million IPO
Mar 7, 2025
04:09 AM EST, 03/07/2025 (MT Newswires) -- Sagtec Global (SAGT) said late Thursday it priced an initial public offering of 1.75 million shares at $4 apiece for about $7 million in expected gross proceeds. The company has granted the book-running manager a 30-day option to acquire up to 262,500 additional shares. The shares are expected to begin trading on Nasdaq...
Patterson-UTI Energy Reports Average Number of Drilling Rigs for February
Patterson-UTI Energy Reports Average Number of Drilling Rigs for February
Mar 7, 2025
04:34 AM EST, 03/07/2025 (MT Newswires) -- Patterson-UTI Energy ( PTEN ) said late Thursday it had an average of 107 drilling rigs operating in the US during February. For the two months ended Feb. 28, the company had an average of 107 drilling rigs operating in the country, it said. ...
China's Xpeng says homegrown brands likely to account for 95% of future domestic EV market
China's Xpeng says homegrown brands likely to account for 95% of future domestic EV market
Mar 7, 2025
HONG KONG, March 7 (Reuters) - The CEO of China's Xpeng He Xiaopeng said on Friday that Chinese homegrown brands will likely make up over 95% of the country's new energy vehicle market in the future. ...
Surmodics Vows to Oppose FTC Decision to Block GTCR Deal
Surmodics Vows to Oppose FTC Decision to Block GTCR Deal
Mar 7, 2025
04:35 AM EST, 03/07/2025 (MT Newswires) -- Surmodics ( SRDX ) said late Thursday it disagrees with the US Federal Trade Commission's decision to challenge the company's proposed acquisition by private-equity firm GTCR, which owns a stake in medical coatings maker Biocoat. The antitrust regulator has sued to block the deal alleging that it's anticompetitive. The proposed merger would result...
Copyright 2023-2026 - www.financetom.com All Rights Reserved